About BIOSINO BIO-TEC Company

Zhongsheng Beikong Biotechnology Co., Ltd. (“Zhongsheng Beikong” or “the Company”) is a leading supplier of in vitro diagnostic (“in vitro diagnosis”) reagents in the People's Republic of China (“China”). The Company and its subsidiaries (collectively, the “Group”) are mainly engaged in R&D, production, sales and distribution of in vitro diagnostic reagent products, and provide high-quality and reliable disease detection reagent products to hospitals and other healthcare institutions. The Company's main equity holders have strong backgrounds. The largest shareholder, Beijing Saipu Asset Management Co., Ltd., is a wholly-owned subsidiary of the Institute of Biophysics (“Institute of Biophysics”) of the Chinese Academy of Sciences (“Chinese Academy of Sciences”). The Institute of Biophysics is one of the most authoritative research institutes in life sciences in China. The Group's brand “Zhongsheng” is famous in the industry. “Zhongsheng” was awarded the “Beijing Famous Brand Product” award in 2002, the “No.1 Brand for Customer Satisfaction Quality and Reputation in the Chinese Diagnostic Reagent Market” award in 2005, and the title of “Famous Trademark of Beijing”, which has been widely recognized by market users and the medical community. The Group has adopted a marketing model combining direct sales and distributors to establish an efficient, stable marketing network covering more than 600 distributors in more than 30 provinces, municipalities and autonomous regions across the country. The Group's diagnostic reagent products are widely sold in domestic hospitals and medical institutions. In addition, the management of the Group includes a number of university professors and PhDs, continuously strengthens the Group's overall competitiveness based on the “people-oriented, innovation, quality first, pursuit of perfection, honest labor and legal management”. Many of the management members have carried out research work at the Institute of Biophysics. Their strong scientific research background and ambitions have laid a good research foundation for Zhongsheng Beikong and also helped the long-term development of the Group's business. The Company's H shares have been listed on GEM since February 27, 2006.